nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Africa CDC campaigns for continental health autonomy
|
Adepoju, Paul |
|
|
|
9 |
p. e650 |
artikel |
2 |
Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis
|
Andrejko, Kristin |
|
|
|
9 |
p. e450-e460 |
artikel |
3 |
A predominant genotype of azole-resistant Candida tropicalis clinical strains
|
Tseng, Kuo-Yun |
|
|
|
9 |
p. e646 |
artikel |
4 |
Assessment of the 2021 WHO Mycobacterium tuberculosis drug resistance mutation catalogue on an independent dataset
|
Hall, Michael B |
|
|
|
9 |
p. e645 |
artikel |
5 |
Association between blood Loa loa microfilarial density and proteinuria levels in a rural area of the Republic of Congo (the MorLo project): a population-based cross-sectional study
|
Campillo, Jérémy T |
|
|
|
9 |
p. e704-e710 |
artikel |
6 |
Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
|
Destras, Grégory |
|
|
|
9 |
p. e424 |
artikel |
7 |
Chlamydia psittaci should be included in veterinary legal quarantine everywhere
|
Zhai, Shao-Lun |
|
|
|
9 |
p. e666 |
artikel |
8 |
Climate change: fires, floods, and infectious diseases
|
The Lancet Microbe, |
|
|
|
9 |
p. e415 |
artikel |
9 |
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial
|
Leung, Nancy H L |
|
|
|
9 |
p. e670-e682 |
artikel |
10 |
Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
|
Lim, Wey Wen |
|
|
|
9 |
p. e423 |
artikel |
11 |
Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study
|
Pickering, Suzanne |
|
|
|
9 |
p. e461-e471 |
artikel |
12 |
Correction to Lancet Microbe 2023; published online July 19. https://doi.org/10.1016/S2666-5247(23)00142-8
|
|
|
|
|
9 |
p. e667 |
artikel |
13 |
Correction to Lancet Microbe 2021; published online June 29. https://doi.org/10.1016/S2666-5247(21)00143-9
|
|
|
|
|
9 |
p. e426 |
artikel |
14 |
Correction to Lancet Microbe 2021; published online June 15. https://doi.org/10.1016/S2666-5247(21)00177-4
|
|
|
|
|
9 |
p. e426 |
artikel |
15 |
Correction to Lancet Microbe 2023; published online June 5. https://doi.org/10.1016/S2666-5247(23)00151-9
|
|
|
|
|
9 |
p. e667 |
artikel |
16 |
Correction to Lancet Microbe 2022; published online May 31. https://doi.org/10.1016/S2666-5247(22)00151-3
|
|
|
|
|
9 |
p. e649 |
artikel |
17 |
Could Egyptian mummies tell us more about the history of coronaviruses?
|
Saied, AbdulRahman A |
|
|
|
9 |
p. e425 |
artikel |
18 |
Crimean–Congo haemorrhagic fever in Iraq
|
Yuan, Shawn |
|
|
|
9 |
p. e669 |
artikel |
19 |
Defining nosocomial transmission of Escherichia coli and antimicrobial resistance genes: a genomic surveillance study
|
Ludden, Catherine |
|
|
|
9 |
p. e472-e480 |
artikel |
20 |
Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study
|
Tumwebaze, Patrick K |
|
|
|
9 |
p. e441-e449 |
artikel |
21 |
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study
|
Zhu, Xianming |
|
|
|
9 |
p. e692-e703 |
artikel |
22 |
Ebola outbreak detection and response since 2013
|
Hampton, Lee M |
|
|
|
9 |
p. e661-e662 |
artikel |
23 |
Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage of Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a randomised controlled trial and controlled human infection study
|
Dula, Dingase |
|
|
|
9 |
p. e683-e691 |
artikel |
24 |
Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis
|
Gao, Ya |
|
|
|
9 |
p. e683-e692 |
artikel |
25 |
Emergence of new IncHI2 multidrug-resistance plasmids carrying VIM-1 metallo-β-lactamase in Escherichia coli in Norway
|
Marathe, Nachiket P |
|
|
|
9 |
p. e663-e664 |
artikel |
26 |
European Congress of Clinical Microbiology & Infectious Diseases 2021
|
Venkatesan, Priya |
|
|
|
9 |
p. e427-e428 |
artikel |
27 |
Evolutionary implications of human transmission of monkeypox: the importance of sequencing multiple lesions
|
Ulaeto, David O |
|
|
|
9 |
p. e639-e640 |
artikel |
28 |
Genomic surveillance to combat COVID-19: challenges and opportunities
|
Robishaw, Janet D |
|
|
|
9 |
p. e481-e484 |
artikel |
29 |
“Global disease detection—free to all.” Or not.
|
The Lancet Microbe, |
|
|
|
9 |
p. e657 |
artikel |
30 |
Highlights from FEMS 2023
|
Molina, Mariano A |
|
|
|
9 |
p. e668 |
artikel |
31 |
Invasive meningococcal disease and genome databases
|
Karlsson, Jens |
|
|
|
9 |
p. e421-e422 |
artikel |
32 |
Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study
|
Marijke Braet, Sofie |
|
|
|
9 |
p. e693-e700 |
artikel |
33 |
Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study
|
Finci, Iris |
|
|
|
9 |
p. e672-e682 |
artikel |
34 |
Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections
|
Karaba, Andrew H |
|
|
|
9 |
p. e644 |
artikel |
35 |
Monkeypox: it could have been different
|
The Lancet Microbe, |
|
|
|
9 |
p. e638 |
artikel |
36 |
Neutralising antibodies against human metapneumovirus
|
Guo, Lei |
|
|
|
9 |
p. e732-e744 |
artikel |
37 |
New guidance for researching acute hepatitis in children
|
Venkatesan, Priya |
|
|
|
9 |
p. e651 |
artikel |
38 |
Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial
|
Yuki, Yoshikazu |
|
|
|
9 |
p. e429-e440 |
artikel |
39 |
Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions
|
Magalhães, Luísa M D |
|
|
|
9 |
p. e711-e722 |
artikel |
40 |
Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK
|
Nadesalingam, Angalee |
|
|
|
9 |
p. e416-e418 |
artikel |
41 |
Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study
|
Watson, Oliver J |
|
|
|
9 |
p. e701-e710 |
artikel |
42 |
Projected burden and duration of the 2022 Monkeypox outbreaks in non-endemic countries
|
Bisanzio, Donal |
|
|
|
9 |
p. e643 |
artikel |
43 |
Responsive modelling of the mpox epidemic in England as a cross-government and academia collaboration: the process, challenges, and lessons learned
|
Panovska-Griffiths, Jasmina |
|
|
|
9 |
p. e658-e660 |
artikel |
44 |
Rising antimicrobial resistance: an evolving epidemic in a pandemic
|
Manesh, Abi |
|
|
|
9 |
p. e419-e420 |
artikel |
45 |
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
|
Jenkin, Daniel |
|
|
|
9 |
p. e663-e671 |
artikel |
46 |
The epidemiology and virulence of carbapenem-resistant Pseudomonas aeruginosa in China
|
Zhu, Ying |
|
|
|
9 |
p. e665 |
artikel |
47 |
Threat from Mycobacterium orygis-associated tuberculosis in south Asia
|
Thapa, Jeewan |
|
|
|
9 |
p. e641-e642 |
artikel |
48 |
Threshold-free genomic cluster detection to track transmission pathways in health-care settings: a genomic epidemiology analysis
|
Hawken, Shawn E |
|
|
|
9 |
p. e652-e662 |
artikel |
49 |
Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation in the USA in 2021: report of an investigation
|
Gould, Carolyn V |
|
|
|
9 |
p. e711-e721 |
artikel |
50 |
Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study
|
Lin, Yun |
|
|
|
9 |
p. e722-e731 |
artikel |
51 |
Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies
|
Buonsenso, Danilo |
|
|
|
9 |
p. e745-e756 |
artikel |
52 |
We should not underestimate the role of biofilms in persistent (chronic) bronchitis
|
Everard, Mark Lloyd |
|
|
|
9 |
p. e647 |
artikel |
53 |
We should not underestimate the role of biofilms in persistent (chronic) bronchitis – Authors' reply
|
Marsh, Robyn L |
|
|
|
9 |
p. e648 |
artikel |